| INTRODUCTION
Dogs with protein-losing enteropathy (PLE) caused by chronic enteropathy (CE) or lymphangiectasia have poor prognosis after failure with immunomodulatory treatment. 1 Although, various studies have aimed to identify prognostic markers in dogs with PLE caused by CE or lymphangiectasia, these have led to variable and inconsistent results. [1] [2] [3] [4] [5] To the authors' knowledge, body condition score (BCS) has been assessed in only 1 study in dogs with PLE caused by CE, which documented that the median BCS at the time of diagnosis was not different between dogs with PLE that had a good or bad outcome. 4 However, this study used a relatively short follow-up period (ie, 4 months) to define outcome and, although not its main intention, it did not assess the effect of BCS adjusting for other variables in a multivariable model.
Abbreviations: AIC, Akaike information criterion; BCS, body condition score; BMI, body mass index; CCEAI, canine chronic enteropathy activity index; CE, chronic enteropathy; CI, confidence interval; GI, gastrointestinal; IBD, inflammatory bowel disease; LRT, likelihood ratio test; PH, proportional hazard; PLE, protein-losing enteropathy; RMST, restricted mean survival time.
Body condition score in dogs is one of the measures used to assess nutritional status. 6, 7 Nutritional status in dogs with PLE caused by CE or lymphangiectasia might be important prognostically, as malnutrition is associated with increased in-hospital death and duration of stay in humans with inflammatory bowel disease (IBD). 8 This study hypothesized that, as malnutrition is associated with a weakened immune system, 9,10 the use of concurrent immunomodulatory treatment in humans with IBD could lead to increased death. As immunomodulatory treatment is commonly used in dogs with PLE caused by CE or lymphangiectasia, the investigation of malnutrition as a predictor for death might not only help prognostication, but might help to determine whether assisted dietary intervention at an earlier stage optimizes response to immunomodulatory treatment and therefore prognosis. Also, if markers of malnutrition are associated with death, then incorporation into index measures of clinical disease activity should be considered.
Although there is no complete agreement on the elements that define malnutrition in human or veterinary medicine, The European
Society for Clinical Nutrition and Metabolism states that the diagnosis of malnutrition in humans should be based on either a body mass index (BMI) of <18.5 or a combined finding of unintentional weight loss with either reduced BMI or a low fat free mass. 11 Single micronutrient deficiencies such as cobalamin and folate can also help to define malnutrition. 12 Serum albumin and BMI are the most predictive of all variables of malnutrition in human IBD patients with active disease. 13 However, BMI and unintentional weight loss together with recent nutrient intake and severity of disease might be more appropriate for the assessment of malnutrition in human IBD patients.
14 Therefore, the aim of our study was to assess whether BCS and other indicators of malnutrition used in human IBD patients, such as body weight, percentage weight loss, appetite, serum albumin, cholesterol, urea, creatinine, cobalamin and folate concentrations, as well as severity of disease and duration of clinical signs at the time of histologic diagnosis can be used as predictors for death after treatment failure in dogs with PLE caused by CE or lymphangiectasia. In our study, severity of disease was estimated using the canine chronic enteropathy activity index (CCEAI), which is based on the presence and severity of 9 factors including attitude/activity, appetite, vomiting, consistency of feces, frequency of defecation, weight loss, serum albumin concentrations, ascites and peripheral edema, and pruritus. 15 2 | MATERIALS AND METHODS
| Data collection
The medical records at the University of Bristol Small Animal Referral an appropriate time-dependent function, and then a covariate with a time-varying effect using the "time transfer" function "tt" in the R package "survival" was created. 17 Explanatory variables included in the final multivariable model were further evaluated individually by using the Kaplan-Meier survival analysis. Quantitative variables were categorized as dichotomous variables for the analysis only when a clinically relevant cut point was possible. A log-rank test was used to test whether the overall survival functions across groups were equal.
The difference in restricted mean survival time (RMST) between groups was tested for 647 days of follow-up (ie, the minimum followup time during which all deaths after treatment failure occurred).
Detailed information about the continuous variables cholesterol concentrations (mmol/L), cobalamin concentrations (pmol/L), and folate concentrations (nmol/L) was only available for 72% of the dogs in the multivariable analysis. Therefore, to avoid reducing the number of dogs included in the multivariable model, the association between these variables and death was only evaluated by univariable Cox PH regression models.
All analyses were carried out using R language version 3.4.1.
17
Cox PH regression analysis and Kaplan-Meier survival analysis were conducted using the R package "survival" 17 and RMST analysis was carried out using the "rmst2" function from the R package "survRM2."
18
Statistical significance was defined as P < .05.
3 | RESULTS
| Study population
Seventy-one dogs with PLE were included in the study: 12 intact males, 33 neutered males, 1 intact female, and 25 neutered females.
The age of the dogs ranged from 1.2 to 13.5 years, with a median age of 7.7 years. Breeds included Staffordshire Bull Terrier (7), Border
Collie (6), cross breed (5), German Shepherd (4), Labrador Retriever 
| Outcome
Twenty-six out of 71 dogs (37%) were alive at the end of the study (n = 24 dogs) or were lost to follow-up (2), and 45 of 71 dogs (63%)
were dead. Of the 45 dogs that were dead at the end of the study, 15 died for reasons other than PLE, 3 died, and 27 were euthanized after treatment failure. Of these 30 dead dogs, 9 failed to respond to a combination of diet, antimicrobial, corticosteroid, and cyclosporine treatment; 6 to a combination of diet, antimicrobial, and corticosteroid treatment; 5 to diet and corticosteroid treatment; 6 to diet, corticosteroid, and cyclosporine treatment; 3 to diet, antimicrobial, corticosteroid, and azathioprine treatment; and 1 to diet, corticosteroid, and azathioprine treatment. The median follow-up time (from the time of PLE histologic diagnosis to death or end of the study, or to the last observation recorded before the animal was lost to follow-up) was 240 days (minimum value -maximum value: 0-2250 days; interquartile range: 1035 days). Median time to death or euthanasia after treatment failure was 41 days (0-647; 121).
| Survival analysis
Results from all the univariable analyses including information on the total number of dogs and events in each model can be found in Table 1 . After univariable screening, variables retained for multivariable modeling were CCEAI, urea (mmol/L), breed, serum albumin concentrations (g/L), and appetite. The most parsimonious model using the AIC criterion was a multivariable model including CCEAI and urea (mmol/L) as explanatory variables. The assumption of PH was met for CCEAI (Z:ph test, P = .65), but it was not satisfied for urea (Z:ph test, P = .006). Thus, urea was modeled as a covariate with a time-varying effect, such that its regression coefficient varied as a linear function of time t (f(t) = log(t + 1)) after adjusting for CCEAI. Results from the final multivariable Cox PH regression model are shown in Table 2 . At any point in time after PLE histologic diagnosis caused by CE or lymphangiectasia, for each unit increase in CCEAI the dogs had experienced, the hazard of death increased by 22.9% (95% confidence interval [CI]: 6.9%-41.2%; Table 2 ), given that urea is held constant.
The time-dependent coefficient for urea is estimated to be ß(t) = 0.528-0.120 * log(t + 1) (P values <.01) (Table 2) indicating that urea has a positive effect on death which decreases over time and drops
off by approximately day 80, given that CCEAI is held constant.
To further explore the association between CCEAI and survival in dogs with PLE, we compared the Kaplan-Meier survival function of 2 groups of dogs formed based on a clinically relevant cutoff for CCEAI of 8, as a CCEAI of ≤8 indicates a CE ranging from insignificant to moderate, whereas a CCEAI of >8 denotes a CE ranging from severe to very severe. The group of dogs with a CCEAI of ≤8 had significantly longer survival time than the group with a CCEAI of >8 throughout the entire follow-up time period (P = .002; Figure 1 ).
Median survival time of the dogs with a CCEAI of ≤8 and with a CCEAI of >8 was undefined (95% CI: 647 -undefined; n = 32) and 109 days (95% CI: 6 -undefined; n = 21), respectively ( Figure 1 ). After following up the dogs for 647 days, the RMST of the dogs with a CCEAI of ≤8 and with a CCEAI of >8 was 504.7 days (95% CI:
418.5-590.9; n = 32) and 248.6 days (95% CI: 126.6-370.5; n = 21)
respectively. Dogs with a CCEAI of ≤8 survived 256.1 days longer (P = .001, 95% CI: 106.7-405.4) than those with a CCEAI of >8 on average, when followed up for 649 days.
The association between urea and survival was further assessed through comparing the Kaplan-Meier survival function of 2 groups of dogs formed based on a cutoff of 7 mmol/L, as this was the upper end of the laboratory reference range for urea. A value for urea of ≤7 mmol/L is considered normal based on our laboratory reference range, whereas a urea value of >7 mmol/L indicates an increased 
| DISCUSSION
The role of malnutrition in the prognosis of dogs with PLE caused by CE or lymphangiectasia has not been extensively studied. Malnutrition is an important comorbidity in human IBD patients with a prevalence as high as 40%. 19 Malnutrition is linked to adverse outcomes 20, 21 and is associated with in-hospital death and increased hospital stay in human IBD patients. 8 Therefore, our study aimed to assess whether markers associated with malnutrition in human IBD patients can be used as predictors for death after treatment failure in dogs with PLE caused by CE or lymphangiectasia. Our study showed that BCS, percentage weight loss, appetite and serum albumin, creatinine, cobalamin, and folate concentrations were not significantly associated with death in dogs with PLE caused by CE or lymphangiectasia after treatment failure.
Our study did show a significant association between the CCEAI and urea concentrations and death in dogs with PLE caused by CE or lymphangiectasia. The CCEAI is an index for clinical severity, which is associated with outcome in dogs with IBD and PLE. 2, 15 The CCEAI was included as a marker of malnutrition in our study as severity of disease is 1 of the variables used for nutrition risk screening in humans as well as for the assessment of malnutrition in human IBD. 14, 22 The CCEAI incorporates serum albumin concentrations, which In our study, body weight, percentage weight loss, and BCS were some of the markers used to assess for malnutrition. However, given does not take into account intra-abdominal fat, muscle condition, or bone density, all of which can be reduced by malnutrition and are therefore likely important in its assessment. 23 Unfortunately, a major limitation of our study was the absence of muscle condition score in our cases and the effect of this on death after treatment failure.
Although, serum creatinine was used in our study as an attempt to act as a surrogate for muscle condition, our study found that this was not a prognostic marker. However, 75% of the dogs in our study had serum creatinine concentrations below the reference range, which
indicates that muscle atrophy is likely prevalent in this disease.
Other limitations of our study include the retrospective study design, which could have made the interpretation of the clinical history and assignment of the CCEAI score inconsistent because of multiple clinician involvement in the cases, especially because 3 of the variables used for assessment of the activity index (lethargy, appetite, and ascites and peripheral edema) involve a subjective scale. 15 Also, BCS is a subjective variable and therefore can differ between clinicians. Some variables, such as serum cholesterol concentrations or appetite, were not assessed or reported in all cases. This limited the number of dogs that were included in the statistical analysis, as only dogs that had complete information for all covariates were included (Table 1) . Also, although all dogs in our study were normobilirubinemic and did not have significant liver or biliary tree abnormalities on abdominal imaging, pre-and postprandial bile acid concentrations to eliminate hepatic dysfunction definitively were not measured for all dogs. Similarly, renal function via the assessment of urinalysis and early biochemical markers for glomerular filtration rate was not assessed for all dogs. Therefore, the presence of possible concurrent hepatic and renal dysfunction, although considered unlikely, could not be definitively eliminated in all dogs. In our study, all but 1 of the deaths related to PLE occurred within the first year of diagnosis and also included 4 dogs that were euthanized or died before discharge from the hospital; therefore, assessing the effects of malnutrition during a specific time period might have allowed for tighter statistical comparisons. Furthermore, regarding dogs that were censored because they died of another cause, these were assumed to die of a competing cause independent of the event in question. Consequently, interpretation of the survival analysis in our study in the presence of competing risks is subject to at least some ambiguity because of uncertainty about the degree of dependence among the competing outcomes. In our study, the diagnosis of CE or lymphangiectasia for all cases was based on histopathology of endoscopic biopsies and not all cases had ileal biopsies performed; therefore, intestinal neoplasia might have been missed in some cases, which would have then impacted the prognosis. Similarly, differences in weighing scales as well as the dog's water balance, especially for those cases of dehydration, hypovolemia, ascites, and peripheral edema could have impacted this measurement.
In conclusion, our study demonstrated that of the markers of malnutrition studied, only the CCEAI and blood urea concentrations were significantly associated with death in dogs with PLE caused by CE or lymphangiectasia. Body condition score, body weight, percentage weight loss, appetite, duration of signs and serum albumin, creatinine, cobalamin, and folate concentrations at the time of histologic diagnosis could not be used as predictors of death after treatment failure in dogs with PLE caused by CE or lymphangiectasia. Alternative measures of malnutrition such as muscle condition score and bone density might be required to definitively investigate the role of malnutrition in the prognosis of PLE in dogs.
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